Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Multiple Sclerosis (MIRROR)
Phase of Trial: Phase IV
Latest Information Update: 28 Jul 2017
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms MIRROR
- 25 Jul 2017 Planned End Date changed from 1 Mar 2017 to 1 Apr 2019.
- 25 Jul 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Apr 2019.
- 20 Jun 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.